Dr. Hingorani talks about a Phase I trial that explores using PEGPH20 in combination with chemotherapy for patients with pancreas cancer He also provides an insightful overview of what makes pancreatic cancer so difficult to treat.
Dr. Venu Pillarisetty
Dr. Pillarisetty is a surgical oncologist who cares for patients with pancreas cancer and other gastrointestinal malignancies.
Dr. Gabriela Chiorean Reports from ASCO 2013
Dr. Gabriela Chiorean talks with Patient Power about two new therapies for pancreatic cancer patients. The first, is a new combination therapy–abraxane plus gemcitabine–is now considered the gold standard for treating patients with metastatic pancreatic cancer. The second is a promising vaccine for pancreatic cancer, called HyperAcute Pancreas, that’s aimed at early stage pancreatic cancer patients.